^Singh R, Sharma M, Joshi P, Rawat DS (2008). “Clinical status of anti-cancer agents derived from marine sources”. Anticancer Agents Med Chem8 (6): 603-617. doi:10.2174/187152008785133074. PMID18690825.
^ abRuan BF, Zhu HL (2012). “The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development”. Curr Med Chem19 (16): 2652-64. doi:10.2174/092986712800493020. PMID22506770.
^Yua X, Yana Y, Gua J-D (2007). “Attachment of the biofouling bryozoan Bugula neritina larvae affected by inorganic and organic chemical cues”. Int Biodeterior Biodegradation60 (2): 81-89. doi:10.1016/j.ibiod.2006.12.003.